DK143757C - Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener - Google Patents

Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener

Info

Publication number
DK143757C
DK143757C DK123476A DK123476A DK143757C DK 143757 C DK143757 C DK 143757C DK 123476 A DK123476 A DK 123476A DK 123476 A DK123476 A DK 123476A DK 143757 C DK143757 C DK 143757C
Authority
DK
Denmark
Prior art keywords
oxoandrosten
disubstituted
preparation
analogy procedure
analogy
Prior art date
Application number
DK123476A
Other languages
Danish (da)
English (en)
Other versions
DK123476A (da
DK143757B (da
Inventor
F Cassidy
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK123476A publication Critical patent/DK123476A/da
Priority to DK102480A priority Critical patent/DK102480A/da
Publication of DK143757B publication Critical patent/DK143757B/da
Application granted granted Critical
Publication of DK143757C publication Critical patent/DK143757C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK123476A 1975-03-21 1976-03-19 Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener DK143757C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK102480A DK102480A (da) 1975-03-21 1980-03-10 Mellemprodukter til fremstilling af 16,16-dialkylsteroider

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series
GB1181975 1975-03-21

Publications (3)

Publication Number Publication Date
DK123476A DK123476A (da) 1976-09-22
DK143757B DK143757B (da) 1981-10-05
DK143757C true DK143757C (da) 1982-03-22

Family

ID=9993275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK123476A DK143757C (da) 1975-03-21 1976-03-19 Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener

Country Status (15)

Country Link
JP (2) JPS51118756A (ru)
AT (1) AT357700B (ru)
AU (1) AU501246B2 (ru)
BE (1) BE839751A (ru)
CA (1) CA1069498A (ru)
CH (2) CH621560A5 (ru)
DE (1) DE2610497C2 (ru)
DK (1) DK143757C (ru)
FR (2) FR2304345A1 (ru)
GB (1) GB1538227A (ru)
IE (1) IE42308B1 (ru)
IL (2) IL49132A (ru)
NL (1) NL184111C (ru)
SE (2) SE7603410L (ru)
ZA (1) ZA761324B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602960A (en) * 1977-05-25 1981-11-18 Beecham Group Ltd Process for preparing 16,16-disubstituted steroids of the androstene series
DE2943778A1 (de) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
DE3514272A1 (de) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen Dermatica
JPS63300153A (ja) * 1987-05-29 1988-12-07 日本碍子株式会社 建築用ほうろうパネル
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
JPH06502161A (ja) * 1990-10-31 1994-03-10 ビーチャム・グループ・パブリック・リミテッド・カンパニー レチノイド浸透作用エンハンサーを含む局所用組成物
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
JPWO2003051903A1 (ja) * 2001-12-19 2005-04-28 中外製薬株式会社 7位及び17位に置換基を有するアンドロスタン誘導体
CN108558975B (zh) * 2018-04-26 2021-03-02 昆明理工大学 12β-羟基-雄甾4,14-二烯-16-酮类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Also Published As

Publication number Publication date
DE2610497A1 (de) 1976-10-07
CH621560A5 (en) 1981-02-13
NL7602949A (nl) 1976-09-23
CA1069498A (en) 1980-01-08
AT357700B (de) 1980-07-25
JPS61178920A (ja) 1986-08-11
NL184111C (nl) 1989-04-17
IL58505A0 (en) 1980-01-31
SE7902256L (sv) 1979-03-13
NL184111B (nl) 1988-11-16
IL49132A0 (en) 1976-05-31
CH631996A5 (en) 1982-09-15
SE7603410L (sv) 1976-09-22
JPS6355488B2 (ru) 1988-11-02
BE839751A (fr) 1976-09-20
AU501246B2 (en) 1979-06-14
FR2304345A1 (fr) 1976-10-15
IE42308B1 (en) 1980-07-16
JPS625920B2 (ru) 1987-02-07
JPS51118756A (en) 1976-10-18
DE2610497C2 (de) 1986-10-16
DK123476A (da) 1976-09-22
GB1538227A (en) 1979-01-10
IE42308L (en) 1976-09-21
AU1220776A (en) 1977-09-22
IL49132A (en) 1980-05-30
FR2304345B1 (ru) 1980-11-07
ATA191376A (de) 1979-12-15
DK143757B (da) 1981-10-05
FR2445340A1 (fr) 1980-07-25
ZA761324B (en) 1977-02-23
FR2445340B1 (ru) 1983-02-11

Similar Documents

Publication Publication Date Title
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK146626C (da) Analogifremgangsmaade til fremstilling af 4'-deoxydaunomycin
DK149107C (da) Analogifremgangsmaade til fremstilling af quinazolonderivater
DK282076A (da) Fremgangsmade til fremstilling af 2,3-dihydro6,7-disubstitueret-5-acyl-benzofuran-2-carboxylsyrer
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK138749C (da) Analogifremgangsmaade til fremstilling af 18-methyl-4,15-oestradiener
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK143757C (da) Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener
DK362676A (da) Fremgangsmade til fremstilling af 1,4-dihydropyridiner
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
DK147070C (da) Analogifremgangsmaade til fremstilling af 13,14-dehydro-11-deoxy-prostaglandiner
DK336676A (da) Fremgangsmade til fremstilling af 1,2,3,4-tetrahydroisoquinoliner
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK142845C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK305076A (da) Fremgangsmade til fremstilling af d,l-pantolacton
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK345477A (da) Fremgangsmaade til fremstilling af 2,3-dichloranisol
DK554176A (da) Fremgangsmade til fremstilling af 3,4-dideoxykanamycin b
DK580076A (da) Fremgangsmade til fremstilling af 6,6,6-trihalogen-3,3-dimethyl-4-hexenoater
DK31676A (da) Fremgangsmade til fremstilling af 1,4-naphthodinitril